These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 8640997)

  • 1. Effects of diuretic therapy on the development of tolerance to nitroglycerin and exercise capacity in patients with chronic stable angina.
    Parker JD; Parker AB; Farrell B; Parker JO
    Circulation; 1996 Feb; 93(4):691-6. PubMed ID: 8640997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of diuretic therapy on exercise capacity in patients with chronic angina and preserved left ventricular function.
    Finimundi HC; Caramori PA; Parker JD
    J Cardiovasc Pharmacol; 2007 May; 49(5):275-9. PubMed ID: 17513945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermittent transdermal nitroglycerin therapy. Decreased anginal threshold during the nitrate-free interval.
    Parker JD; Parker AB; Farrell B; Parker JO
    Circulation; 1995 Feb; 91(4):973-8. PubMed ID: 7850984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute and chronic antianginal efficacy of continuous twenty-four-hour application of transdermal nitroglycerin. Steering Committee, Transdermal Nitroglycerin Cooperative Study.
    Am J Cardiol; 1991 Nov; 68(13):1263-73. PubMed ID: 1951111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdermal isosorbide dinitrate in angina pectoris: effect of acute and sustained therapy.
    Parker JO; VanKoughnett KA; Fung HL
    Am J Cardiol; 1984 Jul; 54(1):8-13. PubMed ID: 6430057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antianginal efficacy of isosorbide dinitrate therapy is maintained during diuretic treatment.
    Sussex BA; Campbell NR; Raju MK; McKay DW
    Clin Pharmacol Ther; 1994 Aug; 56(2):229-34. PubMed ID: 8062500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of diuretic therapy on the development of tolerance during continuous therapy with nitroglycerin.
    Parker JD; Farrell B; Fenton T; Parker JO
    J Am Coll Cardiol; 1992 Sep; 20(3):616-22. PubMed ID: 1512341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of supplemental L-arginine on tolerance development during continuous transdermal nitroglycerin therapy.
    Parker JO; Parker JD; Caldwell RW; Farrell B; Kaesemeyer WH
    J Am Coll Cardiol; 2002 Apr; 39(7):1199-203. PubMed ID: 11923046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermittent transdermal nitroglycerin therapy in angina pectoris. Clinically effective without tolerance or rebound. Minitran Efficacy Study Group.
    Parker JO; Amies MH; Hawkinson RW; Heilman JM; Hougham AJ; Vollmer MC; Wilson RR
    Circulation; 1995 Mar; 91(5):1368-74. PubMed ID: 7867175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic effects of transdermal nitroglycerin in stable angina pectoris: a within-patient, placebo-controlled study.
    Gibelli G; Negrini M; Bruno AM; Fiorini GL; Lambiase M; Magenta G; Corti D; Prina L; Pollavini PG; De Ponti C
    Int J Clin Pharmacol Ther Toxicol; 1989 Sep; 27(9):436-41. PubMed ID: 2509380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diuretic therapy and angina pectoris.
    Parker JD
    Cardiologia; 1998 Mar; 43(3):261-5. PubMed ID: 9611853
    [No Abstract]   [Full Text] [Related]  

  • 12. Failure of transdermal nitroglycerin to improve exercise capacity in patients with angina pectoris.
    Sullivan M; Savvides M; Abouantoun S; Madsen EB; Froelicher V
    J Am Coll Cardiol; 1985 May; 5(5):1220-3. PubMed ID: 3921585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II-receptor antagonist losartan does not prevent nitroglycerin tolerance in patients with coronary artery disease.
    Longobardi G; Ferrara N; Leosco D; Abete P; Furgi G; Cacciatore F; Corbi G; Pescatore R; Rengo F
    Cardiovasc Drugs Ther; 2004 Sep; 18(5):363-70. PubMed ID: 15717138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transdermal nitroglycerin in angina pectoris.
    Parker JO; Fung HL
    Am J Cardiol; 1984 Sep; 54(6):471-6. PubMed ID: 6433687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermittent transdermal nitrates do not improve ischemia in patients taking beta-blockers or calcium antagonists: potential role of rebound ischemia during the nitrate-free period.
    Freedman SB; Daxini BV; Noyce D; Kelly DT
    J Am Coll Cardiol; 1995 Feb; 25(2):349-55. PubMed ID: 7829787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
    Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
    JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transdermal nitroglycerin in angina pectoris: efficacy of intermittent application.
    Luke R; Sharpe N; Coxon R
    J Am Coll Cardiol; 1987 Sep; 10(3):642-6. PubMed ID: 3114351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained effects of transdermal nitroglycerin in patients with angina pectoris.
    Kapoor AS; Dang NS; Reynolds RD
    Clin Ther; 1985; 7(6):674-9. PubMed ID: 3935313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The development of tolerance to continuous transdermal nitroglycerin therapy in patients with angina of effort and mixed angina].
    Cianfrocca C; Sabia R; Zoboli S; Bugiardini R
    G Ital Cardiol; 1993 May; 23(5):439-49. PubMed ID: 8339869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable angina.
    DeMots H; Glasser SP
    J Am Coll Cardiol; 1989 Mar; 13(4):786-95. PubMed ID: 2494240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.